Find clinical trials for Triple Negative Breast Cancer in Tampa, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Tampa, FL, USA:
inhibitor as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study...
Phase 1
Tampa, Florida, United States and 4 other locations
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...
Phase 3
Tampa, Florida, United States and 70 other locations
with stereotactic radiation (SRS) in participants with metastatic triple negative breast cancer with brain metast...
Phase 1, Phase 2
Tampa, Florida, United States
(a modified herpes simplex 1 virus that can specifically destroy cancer cells while leaving normal cells alone) injected directly into the t ...
Phase 1, Phase 2
Tampa, Florida, United States
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Tampa, Florida, United States and 49 other locations
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Tampa, Florida, United States and 23 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Tampa, Florida, United States and 144 other locations
the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple...
Phase 3
Saint Petersburg, Florida, United States and 136 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Tampa, Florida, United States and 508 other locations
This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 will be a single-arm study of intratumoral tavokinogene telseplasmid (TAVO)...
Phase 2
Tampa, Florida, United States and 13 other locations
Clinical trials
Research sites
Resources
Legal